Who
Elizabeth Buck
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Black Diamond Therapeutics.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Feb 2022
- Last trade
- 21 Jan 2026
- Last filed
- 23 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Jan 2026filed 23 Jan 2026 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 21 Jan 2026filed 23 Jan 2026 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 30 Jan 2025filed 31 Jan 2025 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 30 Jan 2025filed 31 Jan 2025 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 14 Feb 2024filed 15 Feb 2024 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 13 Feb 2023filed 15 Feb 2023 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 15 Feb 2022filed 17 Feb 2022 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.